
Bioorganic and Medicinal Chemistry Letters p. 1547 - 1552 (1996)
Update date:2022-08-02
Topics:
Woods, Keith W.
Brooks, Clint D. W.
Maki, Robert G.
Rodriques, Karen E.
Bouska, Jennifer B.
Young, Patrick
Bell, Randy L.
Carter, George W.
Reference FLAP inhibitors 1 and 2 were converted into the corresponding O-acetic acid oxime congeners 8 and 11a, respectively, resulting in potent, orally active, leukotriene biosynthesis inhibitors. An attempt to create a dual FLAP and direct 5-LO inhibitor by replacing the carboxylate group in 1 with the N-hydroxyurea pharmacophore did not provide superior inhibitors.
View MoreYanCheng LongShen Chemical Co.,Ltd.
Contact:+86-515-86668866
Address:No.13,Weiyi Road,Funing Aoyang Industrial Park
Compro Shijiazhuang Fine Chemical Co., Ltd
Contact:0086-311-89689838
Address:Economic and Technological Development Zone of Shijiazhuang,Hebei
suzhou chukai pharmateach co,.ltd
Contact:86-512-88812511
Address:Building 3, Wujiang Scientific Innovation Park, 2358 Changan Rd, Wujiang 215200, Jiangsu Province, P. R. China
Hangzhou Sartort Biopharma Co., Ltd
website:http://www.sartort.com
Contact:86-571-87039693
Address:No. 57, Tech Park Road, Hangzhou, Zhejiang, China
Chongqing KonAo Health Co.,Ltd
Contact:13687578375
Address:wuhan hubei china
Doi:10.1248/cpb.33.4275
(1985)Doi:10.1080/00397919908086040
(1999)Doi:10.1016/j.tet.2006.07.007
(2006)Doi:10.1021/acs.joc.6b02102
(2016)Doi:10.1007/s12272-013-0006-9
(2013)Doi:10.1002/hlca.201200490
(2012)